ALPRAZIREX, created in 1999 (France), from 2757 sister brands and 17477 competing brands. The ALPRAZIREX brand is owned by SANOFI, a company listed in Paris. Its International Securities Identification Number (ISIN) is FR0000120578. ALPRAZIREX belongs to the Drug Manufacturers business sector.